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In Brief
Structural and biochemical data provide insights into the two-step mechanism by which the SidE family of effector proteins ubiquitinate several human proteins without engaging the canonical ubiquitin machinery.
INTRODUCTION
Ubiquitination is one of the most abundant post-translational modifications that influences a broad spectrum of cellular functions in eukaryotes (Iconomou and Saunders, 2016) . Conventional ubiquitination requires ATP and is achieved by the concerted action of the activating (E1), conjugating (E2), and ligating (E3) enzymes, ultimately resulting in an isopeptide bond between the C terminus of ubiquitin and an acceptor lysine residue of the substrate protein (Husnjak and Dikic, 2012) . In addition to monoubiquitination, ubiquitin chains can also be formed on the N-terminal methionine residue (M1) and all seven intrinsic lysine residues (K6, K11, K27, K29, K33, K48, and K63) within a ubiquitin molecule (Rajalingam and Dikic, 2016) . Like most post-translational modifications, ubiquitination is a reversible process, with ubiquitin removal catalyzed by deubiquitinases or DUBs (Komander et al., 2009) .
Given the importance of ubiquitination in many cellular processes including the regulation of the immune system, it is not surprising that the ubiquitination network is exploited by a variety of microbial pathogens (Lin and Machner, 2017; Zhou and Zhu, 2015) . For example, many bacterial effector proteins modulate ubiquitination by functioning as molecular mimics of E3 ligases and DUBs or as enzymes that modify components of the ubiquitination cascade (Lin and Machner, 2017; Zhou and Zhu, 2015) . It should be noted that the conventional E1-E2-E3 machinery is always required for the previously identified ubiquitination processes, regardless of whether the enzymes are derived from the host cells or from pathogens. A paradigm shift away from this fundamental principle came with the discovery of the SidE family of Legionella pneumophila effector proteins, which catalyzes ubiquitination in an E1/E2-independent manner (Qiu et al., 2016) . The SidE family, including four large proteins (SidE, SdeA, SdeB, and SdeC), was found to be required for efficient intracellular bacterial replication (Bardill et al., 2005; Luo and Isberg, 2004) . Starting from the N terminus, SidE family proteins consist of four domains: a DUB domain, a phosphodiesterase (PDE) domain, a mono-ADP-ribosyltransferase (mART) domain, and a coiled-coil (CC) domain (Bhogaraju et al., 2016; Qiu et al., 2016; Sheedlo et al., 2015) . The mART domain of the SidE family can covalently attach the ADP-ribose moiety of the cofactor NAD (nicotinamide adenine dinucleotide) to the R42 residue of ubiquitin to form the activated ADP-ribosylated ubiquitin (ADPr-Ub) intermediate (Qiu et al., 2016) . This intermediate is subsequently catalyzed by the PDE domain to release AMP and phospho-ribosylated ubiquitin (Pr-Ub), which is the ubiquitin moiety that is ultimately attached to the serine residue of substrate proteins through a phosphor-ribosyl linkage (Bhogaraju et al., 2016) .
SidE family proteins have been found to be able to catalyze the non-canonical ubiquitination of several different substrate proteins, including Rab small GTPases, Reticulon-4 (Rtn4), and Rag small GTPases, as well as SidE proteins themselves (Bhogaraju et al., 2016; De Leon et al., 2017; Kotewicz et al., 2017; Qiu et al., 2016) . Unlike conventional ubiquitination, this non-canonical modification is resistant to regular DUBs Qiu et al., 2016) and can only be removed by a newly identified effector protein, SidJ, from L. pneumophila . Interestingly, in addition to adding the Pr-Ub modification to a substrate protein, SidE proteins can also produce free Pr-Ub molecules by removing the AMP moiety from the ADPr-Ub intermediate (Bhogaraju et al., 2016) . More importantly, both ADPrUb and Pr-Ub molecules produced by SidE proteins were shown to attenuate the conventional ubiquitination cascade, leading to a broader and more severe disturbance of essential ubiquitindependent cellular processes (Bhogaraju et al., 2016) . A recent study showed that the M1-, K11-, K48-, and K63-linked diubiquitin chains could also be modified by the SidE family in a similar fashion to free ubiquitin, further broadening the scope of functions of this non-canonical modification .
In addition to SidE proteins, other mART-domain-containing enzymes have also been identified in phages, bacteria, and eukaryotic cells (Glowacki et al., 2002; Hottiger et al., 2010) . It has been suggested that intracellular mono-ADP-ribosylation plays important roles in many eukaryotic cellular processes, including signal transduction, gene expression, cell differentiation, and cell proliferation (Corda and Di Girolamo, 2003; Di Girolamo et al., 2005; Table S1 .
mechanism of substrate recognition by mART enzymes is still largely unclear. A better understanding of the catalytic mechanism of SidE proteins will provide insights into both non-canonical ubiquitination and protein ADP-ribosylation. Here, we report the crystal structures of SidE alone and in complex with ubiquitin, NAD, and ADP-ribose. The structures show a number of unexpected features of this all-in-one ubiquitination machinery and provide the structural explanations for many previous functional observations. Further, our structural and biochemical results also provide new insights into the molecular mechanisms underlying substrate recognition and the two reaction steps of SidE proteins.
RESULTS

Overall Structure of SidE
Given that PDE and mART domains represent the core catalytic region of SidE proteins (Bhogaraju et al., 2016; Qiu et al., 2016) , we designed several SidE constructs containing these two domains for structural determination. The construct used in this study (residues 222-1057, denoted as SidE C ) ( Figures 1A and S1 ) possesses the activity of both SidE auto-ubiquitination and ubiquitination of different substrate proteins ( Figure S2A ). We also observed robust ubiquitination activity for Rab1a in a time-dependent manner ( Figure S2B ), further confirming that SidE C represents an active construct.
We first tried co-crystallization of SidE C and ubiquitin and determined the crystal structure to a 2.7 Å resolution with good R-factors and stereochemistry ( Figure 1B ; Table S1 ). There are two SidE C molecules in one asymmetric unit. Residues 485-493 and 849-855 of each SidE C molecule were not built due to the lack of electron density. Although ubiquitin was included in the initial sample and is important for crystal formation, ubiquitin was not found in the electron density map. We speculated that the reaction had occurred during the crystallization process and the final Pr-Ub molecule was released from the enzyme. Surprisingly, the two SidE C molecules in one asymmetric unit form a previously uncharacterized homodimer through their CC domains ( Figure 1B) . The helical CC domain from one monomer protrudes out and inserts into the cavity formed by CC and mART domains of the other monomer, forming a domain-swapped conformation ( Figure 1B) . The SidE C monomer exhibits an extended and linearized domain organization, with the long dimension being over 160 Å ( Figures 1B and S2C ). The mART domain is localized in the middle and flanked by PDE and CC domains at each side ( Figure 1B ). Each domain itself adopts a stable conformation and can be well superimposed between the two monomers ( Figure S2D ). Although the PDE-mART dual domain forms a rigid inter-domain conformation, the relative orientation between the PDE-mART dual domain and CC domain is dynamic due to the flexible hinge region between the mART and CC domains ( Figure S2C ). The catalytic pockets of the mART and PDE domains where the predicted catalytic residues reside are far from each other and face in different directions ( Figure 1B) , suggesting that the two catalytic steps of non-canonical ubiquitination are likely independent of each other. This is consistent with the previous biochemical assay showing that a shorter construct of SdeA containing only the mART domain could still catalyze the ADP-ribosylation of ubiquitin (Qiu et al., 2016) . We further found that the PDE domain alone can also catalyze Rab1a ubiquitination by using the purified ADPr-Ub intermediate ( Figure S2E ).
PDE Domain
The PDE domain contains two lobes: a larger helical core lobe containing the catalytic pocket and a smaller cap lobe covering from the top ( Figure 1C ). The core lobe possesses the typical phosphodiesterase fold with a bundle of 13 helices and one small b-hairpin ( Figures 1C and S1 ). The cap lobe is a large insertion (E450-L541) between a9 and a12, which exists in all SidE family members ( Figure S1 ). The two lobes together form a long and wide groove with the catalytic pocket located in the middle ( Figure 1C ). The structure reveals that the previously predicted PDE domain of the SidE family (Bhogaraju et al., 2016; Wong et al., 2015) is inaccurate and misses a large portion of the cap lobe as well as three a helices (a12-a14) of the core lobe. A Dali search identified L. pneumophila effector lpg1496, which contains a PDE domain (Wong et al., 2015) , as most closely resembling the fold of the SidE PDE domain, with a Z-score of 24.0 and root-mean-square deviation (RMSD) of 2.3 Å . Compared with SidE PDE, lpg1496 PDE contains two protruding long loops connecting a1-a2 and a3-a4 but does not comprise the cap lobe insertion ( Figure S2F ).
mART Domain
The mART domain also comprises two lobes separated by a deep NAD-binding cleft ( Figure 1D ). The N-terminal lobe possesses a compact a-helical fold with nine a helices and a small b-hairpin ( Figure 1D ). The C-terminal lobe is composed of a two-leaved, highly twisted b sheet that is surrounded by four a helices ( Figure 1D ). The conserved R-S-E residues (R761-S815-E857) reside in the C-terminal lobe and line up on the surface of the deep cleft ( Figure 1D ). A Dali server search revealed that the core region of the SidE mART domain adopts a conserved scaffold characteristic of the R-S-E motif containing the ADP-ribose transferase family (Jeong et al., 2011; Ritter et al., 2003) . Although the core fold could be superimposed well among different mART domains, the motifs outside of the core fold, which may contribute to substrate binding (Jeong et al., 2011) , show diverse structures and conformations ( Figure S2G ).
Inter-domain Interactions between PDE and mART
The mART and PDE domains form a rigid rather than a flexible inter-domain conformation through extensive inter-domain interactions (Figures 2A and S2C) . A protruding helix-loop-helix motif (a23/L784-792/a24) of mART domain binds into a cleft formed by a2, a9, and a14 of PDE domain (Figures 2A and 2B ). L788 and F789, two highly conserved residues among SidE family members ( Figure S1 ) and located at the tail of the helix-loop-helix motif, insert into a hydrophobic pocket formed by both the cap and core lobes of the PDE domain ( Figure 2C ). In addition, a14 also forms hydrogen bonds and hydrophobic interactions with the b sheet of mART C-lobe ( Figure S3A ). Given that the interaction surface does not directly interfere with the catalytic pockets of both mART and PDE domains, we initially anticipated that the loss of inter-domain interactions will not affect the catalytic process. However, to our surprise, both the double mutant L788D/F789D and the deletion of L786-791 significantly decreased the catalytic activity of SidE ( Figure 2D ). In line with the mutation assays, the combination of separated wild-type mART and PDE domains (for both SidE and SdeA) also dramatically affect the ubiquitination process ( Figure 2D ), indicating that the inter-domain interaction cannot be properly reassembled by simply mixing the separated mART and PDE domains. To specifically confirm whether these mutations affect the PDE domain activity, we conducted both Rab1a ubiquitination and AMP-Glo assays by mixing the purified ADRr-Ub intermediate with either wild-type or mutant enzymes. The results show that the mutations of the inter-domain interaction will indeed affect the PDE domain activity (Figures 2E and 2F) . Mass spectrometry analysis of ubiquitin treated with either wild-type SidE or L788D/F789D mutant reveals that the mutant caused accumulation of both ubiquitin and ADPr-Ub intermediate ( Figure S3B ), which indicates that the loss of interdomain interactions will affect both reaction steps.
CC-Domain-Mediated SidE Dimer
The CC domain in our current SidE C construct is composed of nine a helices (a27-a35), which form a helix bundle (a28-a33) at one side and a bifurcation (a27, a34, and a35) at the other (Figures 2G , S1, and S3C). The bifurcation parts from the two monomers complement each other and form a helix bundle structure, which mediates the dimerization of SidE C ( Figures 2G and S3C ). SidE C dimerization is mainly mediated by hydrophobic interaction ( Figure 2G ) as well as by a few hydrogen bonds. Consistent with the structure, SidE C was eluted as a dimer on the size-exclusion chromatography column ( Figure S3D ). Further deletions of a29-a35 (SidE ) and a27-a35 (SidE 222-916 ) were both eluted as monomers ( Figure S3D ), indicating that these deletions affect SidE dimerization. Analytical ultracentrifuge analysis also shows that SidE behave mainly as dimer and monomer, respectively ( Figure S3E ). The CC domains and the dimerization surface are located outside of the PDE-mART catalytic region, suggesting that the CC domain is unlikely to be involved in either the catalytic process or protein folding. Consistent with the structural prediction, no notable difference in the catalytic activity was observed with or without the CC domain ( Figure S3F ).
mART Bound to Ubiquitin
To determine the structure of ubiquitin in complex with the mART domain, we introduced mutations on either SidE or ubiquitin to The purified ADPr-Ub intermediate was treated with SidE C WT and mutant L788/F789D. The released AMP was measured using AMP-Glo assay in different time points. Each experiment was done in triplicate, and the data were analyzed using Graphpad Prism software. The error bars represent mean ± SEM. (G) The CC domain-mediated dimerization (up) and the detailed hydrophobic interactions within the dimer surface (down). The two monomers was colored in green and brown, respectively. See also Figure S3 and Table S1 . 
trap the reaction at the first step. After extensive screening, only the complex of wild-type SidE C and mutant ubiquitin (R42A) gave well-diffracted crystals. The final structure was refined to 2.49 Å resolution with good refinement statistics ( Figure 3A ; Table S1 ). All the amino acids of ubiquitin could be readily traced based on the well-defined electron density ( Figure S4A ). Ubiquitin is attached to one end of the NAD-binding cleft of the mART domain through interactions with a specific surface formed by both the N-and C-terminal lobes ( Figure S4B ). The loop 849-855, which was disordered in apo form SidE ( Figure 1B ), became ordered in the SidE-ubiquitin complex due to interaction with ubiquitin ( Figures 3A and S4B ). The interaction surface in the mART domain comprises two small acidic pockets, which were filled by the two arginine residues (R72 and R74) of ubiquitin ( Figure 3B ). Most of the intermolecular interactions were mediated by the C-terminal tail of ubiquitin (L71-G76) and the mART domain ( Figures 3C and S4C ). The C terminus of ubiquitin points into the solvent and has no close contacts with SidE (Figures 3B, 3C, and S4B). This provides the structural explanation for the previous biochemical results, which showed that the ubiquitin derivative containing either alanine substitution of the last two glycine residues or a six-histidine tag attached to its C terminus did not affect the ubiquitination process (Qiu et al., 2016) . In addition to the C-terminal tail, Q49 of ubiquitin also forms hydrogen bonds with both N709 of SidE and R72 of ubiquitin, which stabilizes the local conformation of R72 ( Figure 3C ). A hydrophobic contact between L8/I44/V70 of ubiquitin and V822/I826/F827 of SidE further anchors the complex conformation ( Figure 3D ).
The amino acids participating in ubiquitin interaction are highly conserved among SidE family members ( Figure S1 ), indicating a conserved mART-ubiquitin interaction surface for SidE proteins. We generated the mutations on the interaction surface between ubiquitin and mART and tested the ubiquitination activities for all these derivatives. Similar to previous results for SdeA (Bhogaraju et al., 2016; Qiu et al., 2016) , both R42A and R72A mutations of ubiquitin abolish the ubiquitination process of SidE ( Figure 3E ). R74A also almost kills the reaction ( Figure 3E ), highlighting the critical role of this residue. Furthermore, the Q49A mutation generates a 2-fold reduction of the SidE activity ( Figure 3E ). In addition, the ubiquitination activity is significantly decreased for the SidE mutants F705A, Q708A, and V822A/I826A/F827A, but not for H701A, D702A, and N709A ( Figure 3F ). To check whether these mART domain mutants will affect the activity of PDE domain, we conducted the Rab1a ubiquitination assay by mixing purified ADRr-Ub intermediate with wild-type and mutant enzymes. The results clearly show that the mutants have the same activity as the wild-type enzyme ( Figure 3G ). Mass spectrometry analysis also reveals that the mutant V822A/I826A/ F827A only causes accumulation of free ubiquitin ( Figure S4D ). Together, these results indicate that the mutants on the Ub-mART interacting surface will only affect the ADP-ribosylation step.
mART Bound to Ubiquitin and NAD Although NAD was included in the SidE C -Ub R42A co-crystallization sample, the electron density for NAD is too weak to build the model ( Figure 3A) . To improve the occupancy and density quality, we soaked SidE C -Ub R42A crystals in a high-concentration NAD solution and determined the NAD-bound structure to 2.85 Å resolution ( Figure S5A ; Table S1 ). NAD binds in the deep cleft of the mART domain ( Figure 4A ), which involves extensive hydrogen bonding and stacking interactions with the residues from both lobes ( Figure 4B ). R761, one of the conserved residues in the R761-S815-E857 motif, undergoes a local conformational change upon NAD binding ( Figure S5B ). Previous work had shown that the substitutions of two conserved glutamic acid residues to alanine (E855 and E857 in SidE) would abolish the SdeA enzyme activity (Bhogaraju et al., 2016; Qiu et al., 2016) . However, the alanine substitution for the conserved S815 only slightly affects the activity, indicating that this residue is not critical for the catalytic process ( Figure 4C ). In addition to the conserved R761-S815-E857 motif, other amino acids participating in NAD binding are also conserved among SidE family members ( Figure S1 ). We showed here that the alanine substitutions for other NAD-interacting residues (N718A, R761A, and Q722A/R724A) also dramatically reduce the ubiquitination activity ( Figure 4C ), further highlighting the critical role of the residues in the NAD-binding pocket. On the other hand, when adding ADRr-Ub intermediate but not free ubiquitin to the reaction mixtures, the mutants show the same activity as the wild-type protein ( Figure 4D ). Further mass spectrometry analysis reveals that the mutant R761A only causes accumulation of free ubiquitin ( Figure S5C ). Together, these results indicate that mutations in the NAD-binding pocket also only affect the first reaction step.
As expected, the nicotinamide ribose moiety of NAD is close to the bound ubiquitin. In the current structure, the distance between the amino group of R72 and the C1 0 atom of nicotinamide ribose is $5 Å ( Figure 4B ). To better understand the reaction process, we modeled back R42 of ubiquitin, which could properly insert into the same acidic pocket as R72 and form hydrogen bonds with both R72 and E855 ( Figure S5D ). Given that the rotamers of the arginine side chain could be easily adjusted, both R42 and R72 have the potential to attack the C1 0 atom of nicotinamide ribose based on distance constraints. . (E and F) In vitro ubiquitination reactions for various ubiquitin mutants (E) and SidE mutants (F) However, previous research has identified that only R42, but not R72, is the active residue to be modified (Bhogaraju et al., 2016) . We hypothesized that R72 may serve as a scaffold to facilitate the proper positioning of R42.
PDE Bound to ADP-ribose
To understand how the PDE domain recognizes and cleaves the ADP-ribose moiety of ADPr-Ub, we soaked the SidE C -Ub R42A crystal in an ADP-ribose solution and determined the structure to 3.0 Å (Table S1 ). Strong omit-map electron density was observed within the ligand-binding groove of PDE, which is sufficient to build the ADP moiety ( Figure S5E ). Extensive hydrogen bonding and stacking interactions were identified between the ADP moiety of ADP-ribose and PDE ( Figures 5B and 5C ). Most of the residues participating in ADP binding are conserved among SidE family members ( Figure S1 ), suggesting a general ligand-binding mechanism. The loop 409-413 between a7 and a8 undergoes a conformational change and moves toward the bound ADP-ribose, with the K411 side chain getting closer to the beta-phosphate of ADP-ribose ( Figures 5C and S5F) . The alanine substitutions for most of the residues that participate in ADP-ribose binding would decrease the ubiquitination activity ( Figures 5D and 5E ). Mass spectrometry analysis reveals that the mutants R334A, W390A, and R409A/K411A cause accumulation of the ADPr-Ub intermediate but not free ubiquitin (Figure S5G) , indicating that the mutations in the ADP-ribose-binding pocket only affect the PDE activity. Strikingly, the nucleotide-binding strategy of the SidE PDE domain is distinct from its closely related homolog lpg1496 (Figure S5H) , which has been used as the model to analyze the ligand recognition mechanism for SidE proteins (Bhogaraju et al., 2016) . In the SidE PDE domain, the ADP moiety of ADPribose binds parallelly on the surface of the groove with its phosphate accessible to the solvent, providing enough space to The asterisks indicate that only the main-chains were shown for these amino acids. (C and D) Indicated SidE proteins were incubated with either free ubiquitin (C) or purified ADPr-Ub intermediate (D) and Rab1a. The reaction mixtures were subjected to SDS-PAGE and stained with Coomassie dye. See also Figure S5 and Table S1 .
connect with the Arg42 residue of ubiquitin ( Figures 5A-5C and S5H). On the other hand, the pyrophosphate of ADP in lpg1496 inserts into a deep and narrow pocket, which hinders the possibility of connection to any additional groups ( Figure S5H ). It should be noted that lpg1496 was crystallized with ADP but not ADP-ribose in the reported structure. Although we cannot exclude the possibility that lpg1496 employs a different recognition mechanism for ADP-ribose, it is unlikely that lpg1496 can bind ADP-ribose in the same way as SidE because several critical amino acids participating in SidE-ADP-ribose interaction are not conserved in lpg1496 ( Figure S5I ).
PDE Bound to Ubiquitin
We determined the crystal structure of ubiquitin bound to the SidE PDE domain to 2.18 Å resolution ( Figure 6A ; Table S1 ). There are two Ub-PDE complexes in one asymmetric unit (Figure S6A) . Ubiquitin is attached to one end of the groove of the PDE domain through interactions with both the cap and core lobes ( Figure 6A ). Upon binding to ubiquitin, both a12 and loop 409-413 undergo local conformational changes to form interactions with ubiquitin. Most of the intermolecular interactions were mediated between the K6-T9 fragment of ubiquitin and the PDE domain ( Figures 6B and 6C ). In addition, H68 of ubiquitin forms a tight hydrogen bond with E461 of PDE, further anchoring the complex conformation ( Figure 6B ). The C-terminal tail of ubiquitin shows different conformations in the two complexes of one asymmetric unit, with R72 and Q272 forming a hydrogen bond in one complex but not in the other ( Figure S6B ). The last two glycine residues of ubiquitin are disordered in both complexes, indicating that these residues are not important for Ub-PDE interaction. R42 side chain of ubiquitin points into the groove but has no contact with the PDE domain ( Figure 6A ). Structural superimposition of the PDE-Ub and SidE C -Ub R42A complexes (with the PDE domain as reference) shows that the two ubiquitin-binding surfaces in the mART and PDE domains are far from each other ( Figure 6D ), further indicating that the two See also Figure S5 and Table S1. reaction steps catalyzed by SidE proteins are independent processes. Alanine substitutions for most of the key residues (in both SidE and ubiquitin) participating in PDE-Ub interactions decrease the ubiquitination activity ( Figures 6E and 6F ), highlighting the critical role of these interactions. The deletion of the cap lobe, which is also critical for ubiquitin interaction, almost abolishes the enzyme activity ( Figure 6G ). Similar to the mutants of ADP-ribose-binding pocket ( Figure S5G ), the cap deletion mutant also only causes accumulation of ADPr-Ub intermediate but not free ubiquitin ( Figure S6C ), indicating that the loss of PDE-Ub interaction will not affect the mART domain activity. We further determined the structure of PDE-Ub in complex with ADP-ribose ( Figure S6D ; Table S1 ). The AMP moiety of ADP-ribose could be built based on the electron density. The same interactions between the AMP moiety of ADP-ribose and PDE were identified as shown in Figures 5B and 5C . The distance between the amino group of R42 and the alpha phosphate of AMP is $13 Å , which is slightly larger than the covalently linked ADPr-Arginine. This indicates that a small structural adjustment may be needed for PDE binding to ADPr-Ub. Figure S2A ), even though Rac1a shares a similar structural fold to other Rab members that can be catalyzed. We hypothesized that SidE proteins do not recognize specific structural folds of substrates but rather can modify a much larger substrate pool as long as the serine residue of the substrate protein can bind into the catalytic pocket of the PDE domain without the steric effect. To prove our hypothesis, we conducted sequence alignment for the Rab proteins, which showed that only the non-catalyzed member Rac1a does not possess the serine-containing N-or C-terminal flexible tails outside the central structured region ( Figure S6E ). To confirm whether these flexible regions represent the major modification sites, we introduced alanine substitutions for the serine residues in either the N-(S2A/S3A) or C-(S188A/S194A/S200A) tails of Rab1a. The N-terminal tail mutation either abolishes (for SidE) or significantly reduces (for SdeA and SdeB) the ubiquitination activity, while the C-terminal mutation has a relatively minor effect ( Figure 7A ). To further map the major modification site of Rab1a, we separately introduced alanine substitutions for the two N-terminal serine residues and found that the S3 position is more critical for ubiquitination activity ( Figure 7B ). We also designed the Rab33b mutant, which carries either the N-(D1-29) or C-terminal (D203-229) tail deletion but still maintains the core fold of the protein. Similar to Rab1a, enzymatic assays show that the N-terminal tail is the major modification region of Rab33b ( Figure S6F ). Although S154 has been found to be one of the ubiquitination sites in Rab33b, the Rab33b S154A mutant does not show any reduced ubiquitination activity (Bhogaraju et al., 2016) . In addition, Rab1a/Rab5a/Rab6a/Rab30-the other four substrates of the SidE enzymes-do not contain serine residue at the same position ( Figure S6E ), further indicating that S154 is not the primary modified position of Rab33b. Together, these results show that the flexible regions outside the central structured domain are the major ubiquitination sites for Rab proteins.
To further confirm that SidE proteins do not recognize specific structural folds, we introduced a random flexible tag containing serine residues to the N terminus of the non-catalyzed Rac1a or Rab33b DN ( Figure 7C ) and conducted in vitro enzymatic assays. As expected, the engineered Rac1a ( Figure 7D ) and Rab33b DN ( Figure 7E ) could be properly modified by SidE proteins. In addition, even though the ubiquitin itself cannot be catalyzed by SidE proteins as a substrate ( Figure 7F ), diubiquitin chains were formed when the same tag was added to the N terminus of uibiquitin ( Figures 7C and 7F ). We also conducted the similar assay to the Glutathione S-transferase (GST) protein, which has a completely different fold with either Rab proteins or ubiquitin, and observed the same results ( Figure S7A ). Together, these results confirm that the SidE family members do not recognize specific folds of substrates but rather can potentially catalyze any protein carrying the accessible serine residue. 
DISCUSSION
The mechanism of ubiquitination was previously found to be universally conserved among different species and to proceed through the canonical E1-E2-E3 cascade. SidE proteins represent the only enzyme family that catalyzes the non-canonical ubiquitination without engaging any of the three-enzyme machinery (Bhogaraju et al., 2016; Qiu et al., 2016) . Despite extensive functional studies of the SidE family, no structural information of this all-in-one ubiquitination machinery has been reported. Here, we report the crystal structures of SidE alone and in complex with ubiquitin and small ligands. The structural and biochemical results provide several new insights into the molecular mechanisms underlying the non-canonical ubiquitination.
The structure of the SidE-ubiquitin complex provides insights not only into ubiquitin recognition but also into protein mono-ADP-ribosylation modification. While protein ADP-ribosylation has been found to be important for many cellular functions, little is known about the mechanism of substrate recognition by mARTs. To our knowledge, only two crystal structures of mARTs bound to their substrate proteins (exotoxin A with eEF2, iotatoxin with actin) have been solved (Jørgensen et al., 2005; Tsuge et al., 2008) . Structure superimposition reveals that these mARTs bind to the substrates using distinct surfaces (Figure S7B ). This further highlights the specificities of substrate recognition by different mARTs. The R-S-E motif containing mARTs are also present in mammalian cells (Glowacki et al., 2002; Hottiger et al., 2010) . The sequence alignments show that the residues participating in SidE-Ub interactions are not conserved in mammalian proteins ( Figure S7C ), indicating that ubiquitin is unlikely to be the substrate for these mammalian enzymes. However, we cannot exclude the possibility that other ADP-ribosyltransferase families in mammalian cells may also recognize ubiquitin.
The structure of SidE bound to ADP-ribose shows a unique ligand-recognition mechanism, which is distinct from the previously identified PDEs. In addition, the unique cap lobe of the PDE domain, which is important for ubiquitin binding, only exists in SidE family proteins. These unique features of the PDE domain, together with the specific ubiquitin-binding surfaces in both mART and PDE domains, provide the specificity of the non-canonical ubiquitination by SidE family proteins. To further confirm the ubiquitin-binding specificity of SidE proteins, we tested the SidE activity against the SUMO (small ubiquitin-like modifier) molecule. Although SUMO shares a similar structural fold to ubiquitin and contains the arginine residue at the same position as R42 in uibiquitin, the residues required for SidEubiquitin interaction are not conserved between SUMO and ubiquitin ( Figure S7D ). As expected, SdeA/SdeB/SidE cannot catalyze the sumoylation reaction ( Figure S7E ), highlighting the specificity of the interaction between ubiquitin and SidE family members.
The CC domain exists in all four SidE family members and mediates the previously uncharacterized dimerization of SidE. Although the constructs with CC domain deletion still maintain the ubiquitination activity in vitro, this dimer structure may serve as a platform to interact with other proteins during pathogen infection, given that the coiled-coil motif is usually involved in the protein-protein interaction. Future functional screening will be needed to search for potential candidates.
Although the C-terminal tail of ubiquitin mediates the majority of interactions with mART domain, no interactions are formed for the last two glycine residues with either mART or PDE domains ( Figures 3C and 6B ). These structure features explain why the ubiquitination process could still occur when introducing mutations or external tags to the C terminus of ubiquitin (Qiu et al., 2016) . Except for K6, which forms a hydrogen bond with the PDE domain, all other lysine residues and the N-terminal methionine residue in ubiquitin are pointing into the solvent and not making contact with SidE ( Figure S7F ). This is in line with previous biochemical data showing that M1-, K11-, K48-, and K63-linked diubiquitin chains can also be modified by SdeA .
Our biochemical assays show that the SidE family proteins could recognize the substrate proteins with different structural folds. Theoretically, any protein could potentially be the substrate of SidE enzymes as long as the protein contains the accessible serine residue that can bind into the catalytic pocket without the steric effect. This feature will certainly be very important for designing molecular tools based on SidE proteins in the future. It is also very likely that more substrates exist for SidE proteins in vivo, which could help explain the potent toxic effect of SidE proteins in cells. An unbiased screen will be needed to identify these proteins.
The crystal structures show that both the active pockets and ubiquitin-binding surfaces of the mART and PDE domains are located far from each other. The biochemical data further confirm that the mutations for either the ubiqtuitin-binding surface or catalytic pocket of PDE have no notable effect on mART activity and vice versa. Together, these data indicate that ubiquitin ADP-ribosylation and substrate ubiquitination are independent processes. Although the mutations of the PDE-mART interface will affect the activities of both domains, the inter-domain interaction does not directly participate in either ubiquitin binding or catalytic reaction. We speculate that the PDE-mART interaction would stabilize the conformations for both mART and PDE domains. Based on our structural and biochemical results, we hypothesized the potential mechanism of SidE proteins: (1) ubiquitin and cofactor NAD bind to the mART domain, with R42 and R72 inserting into the catalytic pocket; (2) with the help of R72, R42 attacks the C1 0 atom of nicotinamide ribose and forms the ADPrUb intermediate; (3) ADPr-Ub releases from the mART domain and diffuses to the ubiquitin-binding surface of the PDE domain, with the ADR-ribose group inserting into the catalytic pocket; and (4) ADPr-Ub is subsequently catalyzed by the PDE domain to release AMP and Pr-Ub, which is simultaneously attached to the serine residue of substrate proteins.
In summary, our work provides detailed information to explain the molecular mechanism of the non-canonical ubiquitination catalyzed by SidE family enzymes. This work will also serve as an important reference in designing tools with potentially farreaching implications.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Top10 Chemically Competent Cells were used for molecular cloning. Rosetta (DE3) Chemically Competent Cells were used for protein expression. Both of them were grown in LB medium culture at 37 C. After induction, Rosetta (DE3) cells were transferred to 20 C.
METHOD DETAILS
Plasmid construction
The genes encoding the SidE family members, including SdeA (UniProt: Q6RCR0), SdeB (UniProt: Q6RCQ9) and SidE (UniProt: Q6RCR1), were amplified from the Legionella pneumophilalem genome using standard PCR method. The gene encoding human ubiquitin was synthesized and codon-optimized for expression in E. coli. The Rab family members, including Rab33b (UniProt: Q9H082), Rab6a (UniProt: P20340), Rab1a (UniProt: P62820), Rab5a (UniProt: P20339) and Rac1a (UniProt: P63000), were amplified from the human genome. The SidE family constructs were inserted into pET-24a between NdeI site and XhoI site with a C-terminal 6XHis tag. The full length ubiquitin, SUMO, glutathione S-transferase (GST) and the Rab family members were cloned into a modified pET-28a vector (pET-28a-m) between BamHI and XhoI sites, in which the genes were separated from the preceding 6XHis-Tev tag by a Tev protease cleavage site. For the Rab family members, the BamHI site (GGATTC, coding Gly-Ser residues) was further mutated to GGAGCG (coding Gly-Ala residues) to ensure that there was no extra serine residue left after the Tev protease cleavage. All the gene sequences were subsequently confirmed by sequencing.
Protein expression and purification
All the recombinant proteins were expressed in Rosetta (DE3) cell strain. The cells were grown at 37 C until OD600 reached approx. 0.8. The temperature was then shifted to 20 C and the cells were induced by addition of isopropyl b-D-1-thiogalactopyranoside (IPTG) to the culture medium at the final concentration of 0.5 mM. After induction, the cells were grown overnight.
All the recombinant proteins were first purified over Ni affinity column. The bacterial cells were suspended in the lysis buffer containing 50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 20 mM imidazole, 5% glycerol, and then the cells were broken by high pressure cracker. After centrifugation, the supernatant was loaded onto the Ni column and then the protein sample was washed with the elution buffer containing 50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 500 mM imidazole, 5% glycerol.
For SidE family members, the Ni column fraction was changed into Q column buffer containing 25 mM Tris-HCl, pH 8.5, 50 mM NaCl. The protein sample was fractionated over the Hitrap Q column with a linear NaCl gradient from 50mM to 1M, followed by gel filtration on a 16/60 G200 Superdex column equipped with the storage buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1 mM DTT. The final sample was concentrated and stored at À80 C before use. The Se-methionine substituted protein was expressed in Se-methionine containing medium and purified following the same protocol used for the wild-type protein.
For ubiquitin, SUMO, GST, and Rab family members, the 6XHis-Tev tag was cleaved by adding Tev protease into the Ni column fraction. Then the protein sample was reloaded onto the Ni column to remove the 6XHis-Tev tag and the Tev protease. The flowthrough was fractioned, concentrated and loaded onto the 16/60 G200 Superdex column equipped with the same buffer used for SidE family members.
For Rac1a, Rab33bDN, GST and ubiquitin, the proteins were also purified without the cleavage of the 6XHis-Tev tag. The Ni column fraction was directly loaded onto the 16/60 G200 Superdex column without adding the Tev protease.
For producing the ADP-ribosylated ubiquitin, 2.5 mM purified ubiquitin was mixed with 5 mM SidE C R334A and 10 mM NAD in a final volume 400 mL buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1 mM DTT. After incubation at 37 C for 1h, the mixture was loaded onto the 16/60 G200 Superdex column equipped with the same buffer.
All the truncated constructs and mutants were cloned and purified following the same protocol used for preparation of the wildtype proteins.
Crystallization
For crystallization of SidE C (SidE 222-1057 , aa 222-1057) in the free state, SidE C was first diluted into about 15 mg/ml and was then mixed with ubiquitin at a molar ratio of 1:1.2 in the storage buffer added with 1 mM NAD. The crystals were generated by hanging drop vapor diffusion method at 20 C, from drops containing 1 mL of the protein sample and 1 mL of reservoir solution (4% Tacsimate pH 7.5,15% PEG3350).
For crystallization of SidE C in complex with ubiquitin R42A , SidE C was mixed with ubiquitin R42A at a molar ratio 1:1.2 in the storage buffer added with 1 mM NAD. The crystal was generated by hanging drop vapor diffusion method at 20 C, from drops containing 1 mL of SidE C -ubiquitin R42A solution and 1 mL of reservoir solution (4% Tacsimate pH 7.3,16% PEG3350). The crystals of Se-methionine substituted sample were grown under the same condition.
For the crystals of SidE C -ubiquitin R42A bound to NAD or ADP-ribose, the SidE C -ubiquitin R42A crystals were soaked in the reservoir solution containing either 30 mM NAD or 30 mM ADP-ribose for 3 h.
For crystallization of PDE domain (aa 222-589) in complex with ubiquitin, PDE was mixed with ubiquitin at a molar ratio 1:1.2 in the storage buffer. The crystals were generated by hanging drop vapor diffusion method at 20 C, from drops containing 1 mL of the protein sample and 1 mL of reservoir solution (0.1M Bicine, pH 8.5, 20% PEG10000). The crystal was soaked in the reservoir solution containing 30 mM ADP-ribose for 3 h to get the PDE-ubiquitin-ADP-ribose ternary complex crystal.
Structure determination
All the diffraction datasets were collected at the Shanghai Synchrotron Radiation Facility (SSRF), and were indexed, integrated and scaled using the HKL program suite (Otwinowski and Minor, 1997) . The structure of SidE C -ubiquitin R42A complex was solved using single-wavelength anomalous dispersion method as implemented in the program PHENIX (Adams et al., 2010) . The structures of SidE C alone, SidE C -ubiquitin R42A bound to NAD, and SidE C -ubiquitin R42A bound to ADP-ribose were all solved by molecular replacement method in PHENIX (Adams et al., 2010) , using the structure of SidE C -ubiquitin R42A complex as the search model. The structures of PDE-ubiquitin complex and PDE-ubiquitin-ADP-ribose complex were also solved by molecular replacement method using the PDE structure modified from the SidEc structure as the search model. Model building and structural refinement for all the structures were carried out using the programs COOT (Emsley et al., 2010) and PHENIX (Adams et al., 2010) , respectively. The statistics of the data collection and refinement were shown in Table S1 .
In vitro ubiquitination assays All the in vitro ubiquitination reactions in this study were carried out at 37 C by using purified proteins in the reaction buffer (50 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1 mM DTT).
For the time-dependent ubiquitination of Rab1a catalyzed by SidE C ( Figure S2B ), the total volume of the reaction system is 10 mL, which contains 55 mM ubiquitin, 0.2 mM SidE C, 9 mM Rab1a and 2 mM NAD. At each indicating time point, the reaction mixture was mixed with 2 mL of 6X SDS-PAGE loading buffer and heated at 94 C for 10 min to stop the reaction. 5.5 mL of each sample was subjected to SDS-PAGE and stained with Coomassie dye.
For the ubiquitination of different Rab GTPases or its N-or C-terminal tail mutations catalyzed by SdeA 230-1062 , SdeB 233-1086 and SidE 222-1057 ( Figures 7A, 7B , S2A, and S6F), each 10 mL reaction system contains 55 mM ubiquitin, 2 mM enzyme, 18 mM substrate and 2 mM NAD. After 4 h of reaction, 2 mL of 6X SDS-PAGE loading buffer was added to the mixture followed by 10 min heating at 94 C. 5.5 mL of each sample was then subjected to SDS-PAGE and stained with Coomassie dye. Same reaction condition was used for the ubiquitination of the substrates carrying the 6XHis-Tev tag (MGSSHHHHHHSSGLVPRGSHMENLYFQGGA) ( Figures 7D-7F and S7A).
For the mutations of SidEc or ubiquitin, the 10 mL reaction system contains 55 mM ubiquitin or its mutants or ADP-ribosylated ubiquitin, 0.2 mM SidEc or its mutants, 9 mM Rab1a with or without 2 mM NAD. The reaction time is either 2 h ( Figures 2D, 3E, 5D , 6E-6G, and S2E) or 3 min ( Figures 2E, 3F , 3G, 4C, 4D, 5E, and S3F). The reaction was stopped by adding 2 mL of 6X SDS-PAGE loading buffer and boiling at 94 C for 10 min. 5.5 mL of each sample was subjected to SDS-PAGE and stained with Coomassie dye. For the reactions of SUMO substitution of ubiquitin ( Figure S7E ), each 10 mL reaction system contains 35 mM SUMO, 2 mM enzymes (SdeA 230-1062 , SdeB 233-1086 and SidE 222-1057 ), 18 mM Rab1a and 2 mM NAD. After 4 h of reaction, 2 mL of 6X SDS-PAGE loading buffer was added to the mixture followed by 10 min heating at 94 C. 5.5 mL of each reaction mixture was then subjected to SDS-PAGE and stained with Coomassie dye.
Mass spectrometric analysis of the modified ubiquitin
The reaction mixture contains 110 mM ubiquitin, 0.2 mM SidEc or its mutants and 4 mM NAD in a final volume 100 mL buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1 mM DTT. The enzymatic reaction was set up at 37
C for 1 h. For analysis of the modified ubiquitin, SidEc or its mutants were removed using 30 kD centrifugal filters (Millipore). Then the samples were desalted by Acclaim 120 C18 chromatography column and subjected to HPLC-Q-TOF-MS system (Agilent). MS spectra data were collected and deconvoluted with MassHunter Qualitutative Analysis software (Agilent) to determine the protein mass. The deconvoluted data were imported to Graphpad Prism software and fitted to curves.
AMP release assay and enzymatic dynamics
The 100 mL enzymatic reaction system contains 40 nM SidEc or its mutants, and 10 mM purified ADP-ribosylated ubiquitin in buffer containing 50 mM Tris-HCl, pH 7.5, 10 mM NaCl, 1 mM DTT. The mixture was incubated at 25 C for 1 min, 2 min, 5 min, 10 min, 20 min, 30 min, 40 min, and 50 min separately. The mixture without enzyme was used as a blank control. At each time point, the reaction mixture was centrifuged at 10000rpm for 1min using 30 kD centrifugal filters (Millipore) to remove enzyme. The run through sample contains the released AMP and measured using AMP-Glo assay (Promega). The assay was set up according to manufacturer's instructions. Briefly, 5 mL of the run through sample was transferred to different wells of a white round-bottomed plate (Bio-rad) and 5 mL of AMP-Glo reagent I was added to each well. The plate was incubated at 25 C for 1 h. Then 10 mL of AMPGlo detection solution was added to each well and the plate was incubated at 25 C for 1 h. Luminescent signal was measured using
Varioskan Flash spectral scanning multimode reader (Thermo Scientific). Three independent experiments were set up for each enzymatic system. The results were imported to Graphpad Prism software, analyzed and fitted to curves.
Analytical ultracentrifugation
Analytical sedimentation velocity experiments were performed using a ProteomeLab XL-I analytical ultracentrifuge system (Beckman Coulter) at 20 C. Both SidE 222-1057 and SidE 222-916 were diluted with buffer (50mM Tris, pH 7.5, 10 mM NaCl) to a concentration of about 1 mg/ml. Samples were loaded onto a conventional double-sector quartz cell, mounted in a Beckman four-hole An-60 Ti rotor and centrifuged at 50 000 rpm. Migration of sample was monitored based on absorbance at 280 nm. Data were calculated and analyzed using the SEDFIT software (http://www.analyticalultracentrifugation.com).
QUANTIFICATION AND STATISTICAL ANALYSIS
Luminescent signal data in Figure 2F are analyzed with Graphpad Prism software and the error bars shown in the figure represent SEM.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the coordinates and structure factors reported in this paper are PDB: 5ZQ2 (SidEc), 5ZQ5 (SidEc+ub R42A ), 5ZQ7 (SidEc+ub R42A +NAD), 5ZQ6 (SidEc+ub Figure S2 . Ubiquitination Activity of SidE C and Structure Superimposition, Related to Figure 1 
